The Biotech Growth Trust PLC (LON:BIOG) Insider Hamish Baillie Buys 1,200 Shares of Stock

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie purchased 1,200 shares of the business’s stock in a transaction that occurred on Thursday, December 19th. The stock was bought at an average cost of GBX 856 ($10.76) per share, for a total transaction of £10,272 ($12,909.39).

Hamish Baillie also recently made the following trade(s):

• On Wednesday, November 27th, Hamish Baillie acquired 3,000 shares of The Biotech Growth Trust stock. The shares were bought at an average price of GBX 931 ($11.70) per share, with a total value of £27,930 ($35,101.17).

The Biotech Growth Trust Stock Performance

BIOG stock opened at GBX 868 ($10.91) on Friday. The Biotech Growth Trust PLC has a 1 year low of GBX 840.94 ($10.57) and a 1 year high of GBX 1,068.36 ($13.43). The stock has a market capitalization of £278.89 million, a price-to-earnings ratio of 419.32 and a beta of 0.50. The company has a debt-to-equity ratio of 13.03, a quick ratio of 0.00 and a current ratio of 0.33. The stock’s fifty day moving average is GBX 970.52 and its two-hundred day moving average is GBX 994.83.

About The Biotech Growth Trust

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.